ICLR
Price
$145.66
Change
-$1.43 (-0.97%)
Updated
Jun 13 closing price
Capitalization
27.35B
38 days until earnings call
MDXH
Price
$2.00
Change
-$0.14 (-6.54%)
Updated
Jun 13 closing price
Capitalization
70.68M
60 days until earnings call
Interact to see
Advertisement

ICLR vs MDXH

Header iconICLR vs MDXH Comparison
Open Charts ICLR vs MDXHBanner chart's image
ICON
Price$145.66
Change-$1.43 (-0.97%)
Volume$1.28M
Capitalization27.35B
MDxHealth SA
Price$2.00
Change-$0.14 (-6.54%)
Volume$220.86K
Capitalization70.68M
ICLR vs MDXH Comparison Chart
Loading...
ICLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICLR vs. MDXH commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICLR is a StrongBuy and MDXH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (ICLR: $145.66 vs. MDXH: $2.00)
Brand notoriety: ICLR and MDXH are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICLR: 78% vs. MDXH: 333%
Market capitalization -- ICLR: $27.35B vs. MDXH: $70.68M
ICLR [@Medical Specialties] is valued at $27.35B. MDXH’s [@Medical Specialties] market capitalization is $70.68M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICLR’s FA Score shows that 0 FA rating(s) are green whileMDXH’s FA Score has 0 green FA rating(s).

  • ICLR’s FA Score: 0 green, 5 red.
  • MDXH’s FA Score: 0 green, 5 red.
According to our system of comparison, MDXH is a better buy in the long-term than ICLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICLR’s TA Score shows that 4 TA indicator(s) are bullish while MDXH’s TA Score has 4 bullish TA indicator(s).

  • ICLR’s TA Score: 4 bullish, 4 bearish.
  • MDXH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ICLR and MDXH are a good buy in the short-term.

Price Growth

ICLR (@Medical Specialties) experienced а +4.71% price change this week, while MDXH (@Medical Specialties) price change was -3.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.80%. For the same industry, the average monthly price growth was +3.14%, and the average quarterly price growth was +0.31%.

Reported Earning Dates

ICLR is expected to report earnings on Jul 23, 2025.

MDXH is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Medical Specialties (-1.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICLR($27.4B) has a higher market cap than MDXH($70.7M). MDXH YTD gains are higher at: -15.612 vs. ICLR (-30.542). ICLR has higher annual earnings (EBITDA): 1.52B vs. MDXH (-26.16M). ICLR has more cash in the bank: 380M vs. MDXH (32.7M). MDXH has less debt than ICLR: MDXH (40.7M) vs ICLR (3.94B). ICLR has higher revenues than MDXH: ICLR (8.12B) vs MDXH (63.7M).
ICLRMDXHICLR / MDXH
Capitalization27.4B70.7M38,755%
EBITDA1.52B-26.16M-5,814%
Gain YTD-30.542-15.612196%
P/E Ratio44.81N/A-
Revenue8.12B63.7M12,747%
Total Cash380M32.7M1,162%
Total Debt3.94B40.7M9,676%
FUNDAMENTALS RATINGS
ICLR vs MDXH: Fundamental Ratings
ICLR
MDXH
OUTLOOK RATING
1..100
2675
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7698
PRICE GROWTH RATING
1..100
6447
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
8529

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDXH's Valuation (53) in the null industry is in the same range as ICLR (70) in the Pharmaceuticals Other industry. This means that MDXH’s stock grew similarly to ICLR’s over the last 12 months.

MDXH's Profit vs Risk Rating (100) in the null industry is in the same range as ICLR (100) in the Pharmaceuticals Other industry. This means that MDXH’s stock grew similarly to ICLR’s over the last 12 months.

ICLR's SMR Rating (76) in the Pharmaceuticals Other industry is in the same range as MDXH (98) in the null industry. This means that ICLR’s stock grew similarly to MDXH’s over the last 12 months.

MDXH's Price Growth Rating (47) in the null industry is in the same range as ICLR (64) in the Pharmaceuticals Other industry. This means that MDXH’s stock grew similarly to ICLR’s over the last 12 months.

ICLR's P/E Growth Rating (97) in the Pharmaceuticals Other industry is in the same range as MDXH (100) in the null industry. This means that ICLR’s stock grew similarly to MDXH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICLRMDXH
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
65%
Momentum
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
69%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
34%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend about 1 month ago
73%
Declines
ODDS (%)
Bearish Trend 14 days ago
65%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 3 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
ICLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INCY67.75-1.47
-2.12%
Incyte Corp
RYI20.78-0.47
-2.21%
RYERSON HOLDING Corp
MTRN78.26-2.48
-3.07%
Materion Corp
TROO0.76-0.03
-3.63%
TROOPS
SNPX3.71-1.15
-23.66%
Synaptogenix

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been closely correlated with IQV. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICLR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
-0.97%
IQV - ICLR
74%
Closely correlated
-1.41%
RGEN - ICLR
62%
Loosely correlated
-2.88%
TMO - ICLR
54%
Loosely correlated
-2.93%
BRKR - ICLR
53%
Loosely correlated
-3.94%
A - ICLR
53%
Loosely correlated
-1.54%
More

MDXH and

Correlation & Price change

A.I.dvisor tells us that MDXH and MEHCQ have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDXH and MEHCQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXH
1D Price
Change %
MDXH100%
-6.54%
MEHCQ - MDXH
28%
Poorly correlated
+6.60%
BNGO - MDXH
28%
Poorly correlated
-1.35%
IRIX - MDXH
27%
Poorly correlated
N/A
ICLR - MDXH
24%
Poorly correlated
-0.97%
CLPT - MDXH
24%
Poorly correlated
-4.47%
More